Suppr超能文献

VYC-17.5L 矫正手部和颈部皮肤凹陷的前瞻性单中心研究。

Correction of Skin Depressions of the Hands and Décolletage With VYC-17.5L: A Prospective, Single-center Study.

出版信息

J Drugs Dermatol. 2020 Dec 1;19(12):1219-1225. doi: 10.36849/JDD.2020.5524.

Abstract

BACKGROUND

Few studies have assessed the use of hyaluronic acid (HA) fillers for rejuvenating the hands and décolletage. VYC-17.5L is an HA filler with physical properties that may be well suited to these areas.

METHODS

This was a prospective study of females undergoing VYC-17.5L treatment in the dorsum of both hands and the décolletage. All had ageing of the hands rated 3–4 on the Allergan Hand Volume Deficit Scale (AHVDS), and of the décolletage rated 3–5 using the Fabi–Bolton Chest Wrinkle Scale (FBCWS). Patients were initially treated with VYC-17.5L up to a maximum of 1.5 mL per hand and 3.0 mL in the décolletage; VYC-17.5L touch up was allowed at 1 month. Subjects were followed up for 12 months. The primary endpoint was the number of responders in each hand and the décolletage at 6 months, defined as a ≥ 1-point improvement on AHVDS or FBCWS.

RESULTS

Thirty-three patients were enrolled (mean age, 56.6 ± 9.9 years). Six-month response rates were 100% in each hand (AHVDS) and 96.9% in the décolletage (FBCWS). Mean improvements were statistically significant at all three sites (P<0.001). At 6 months, patient satisfaction using the Global Aesthetic Improvement Scale was high: 81.3% rated their right and left hands as ‘improved’ or ‘much improved’; 65.6% rated their décolletage this way. Results were durable out to 12 months for all endpoints. There were no unexpected safety findings.

CONCLUSIONS

VYC-17.5L was effective and safe for correction of skin depressions of the hands and décolletage. J Drugs Dermatol. 2020;19(12): doi:10.36849/JDD.2020.5524.

摘要

背景

鲜有研究评估透明质酸(HA)填充剂对手部和颈部年轻化的作用。VYC-17.5L 是一种具有物理特性的 HA 填充剂,可能非常适合这些部位。

方法

这是一项前瞻性研究,共纳入 33 名手部和颈部老化 3-4 级(采用 Allergan 手部容量缺损量表[AHVDS]评估)的女性,其中 3-5 级(采用 Fabi–Bolton 胸部皱纹量表[FBCWS]评估)。所有患者均接受 VYC-17.5L 治疗,手部初始剂量最高为 1.5 mL/侧,颈部为 3.0 mL;1 个月后允许进行 VYC-17.5L 补充治疗。患者随访 12 个月。主要终点为 6 个月时手部和颈部的应答者数量,定义为 AHVDS 或 FBCWS 至少改善 1 分。

结果

共纳入 33 名患者(平均年龄 56.6 ± 9.9 岁)。手部和颈部的 6 个月应答率均为 100%(AHVDS)和 96.9%(FBCWS)。所有 3 个部位的平均改善均具有统计学意义(P<0.001)。6 个月时,使用整体美学改善量表评估,患者对右侧和左侧手部的满意度较高:81.3%的患者认为其手部“改善”或“明显改善”;65.6%的患者认为其颈部“改善”或“明显改善”。所有终点在 12 个月时结果均持久。未发现意外的安全性问题。

结论

VYC-17.5L 治疗手部和颈部皮肤凹陷有效且安全。J 皮肤病药物治疗学杂志。2020;19(12):doi:10.36849/JDD.2020.5524。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验